SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19662347
Source:
http://linkedlifedata.com/resource/pubmed/id/19662347
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0011923
,
umls-concept:C0020456
,
umls-concept:C0032743
,
umls-concept:C0205191
,
umls-concept:C0205210
,
umls-concept:C0205478
,
umls-concept:C0237881
,
umls-concept:C0750502
,
umls-concept:C1706089
pubmed:issue
7
pubmed:dateCreated
2009-9-18
pubmed:abstractText
The purpose of this study was to evaluate the adverse effects of chronic marked hyperglycemia on clinical diagnostic performance of positron emission tomography (PET) using (18)F-fuorodeoxyglucose (FDG).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8913398
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose
,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorodeoxyglucose F18
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1864-6433
pubmed:author
pubmed-author:HaraTadashiT
,
pubmed-author:HigashiTatsuyaT
,
pubmed-author:IshimoriTakayoshiT
,
pubmed-author:IshizuKoichiK
,
pubmed-author:KawaseShigetoS
,
pubmed-author:KawashimaHidekazuH
,
pubmed-author:MatsumotoKeiichiK
,
pubmed-author:NakamotoYujiY
,
pubmed-author:SagaTsuneoT
,
pubmed-author:SugaTsuyoshiT
,
pubmed-author:TogashiKaoriK
pubmed:issnType
Electronic
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
657-69
pubmed:meshHeading
pubmed-meshheading:19662347-Adult
,
pubmed-meshheading:19662347-Aged
,
pubmed-meshheading:19662347-Blood Glucose
,
pubmed-meshheading:19662347-Chronic Disease
,
pubmed-meshheading:19662347-Diabetes Complications
,
pubmed-meshheading:19662347-False Negative Reactions
,
pubmed-meshheading:19662347-False Positive Reactions
,
pubmed-meshheading:19662347-Female
,
pubmed-meshheading:19662347-Fluorodeoxyglucose F18
,
pubmed-meshheading:19662347-Humans
,
pubmed-meshheading:19662347-Hyperglycemia
,
pubmed-meshheading:19662347-Male
,
pubmed-meshheading:19662347-Middle Aged
,
pubmed-meshheading:19662347-Neoplasms
,
pubmed-meshheading:19662347-Positron-Emission Tomography
,
pubmed-meshheading:19662347-Retrospective Studies
pubmed:year
2009
pubmed:articleTitle
Significance of chronic marked hyperglycemia on FDG-PET: is it really problematic for clinical oncologic imaging?
pubmed:affiliation
Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
pubmed:publicationType
Journal Article